ACIU
AC Immune S.A.
ACIU lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ACIU Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
ACIU's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ACIU PE Valuation
ACIU has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ACIU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect ACIU to return to profit, with revenue growing.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
ACIU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.52 | +$0.08 |
| Q1 2026 | -$0.79 | -$0.16 |
| Q4 2025 | -$0.84 | -$0.23 |
| Q3 2025 | -$0.85 | -$0.35 |
| Q2 2025 | -$0.60 | +$0.18 |
| Q1 2025 | -$0.63 | +$0.11 |
| Q4 2024 | -$0.61 | +$0.17 |
| Q3 2024 | -$0.50 | +$0.48 |
ACIU has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
ACIU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | +1057% |
| Q1 2026 | $1.3M | +13% |
| Q4 2025 | $406.9K | -70% |
| Q3 2025 | $1.1M | -96% |
| Q2 2025 | $1.6M | +90% |
| Q4 2024 | $1.4M | -92% |
| Q4 2023 | $17.8M | +1479813% |
| Q4 2020 | $1.1M | +9.8% |
ACIU's revenue is recovering but still below its 2019 peak: $18M last quarter, up 1057% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.9% | +1492 points |
| Q1 2026 | -1322% | +635 points |
| Q4 2025 | -4262% | -2625 points |
| Q3 2025 | -1722% | -1750 points |
| Q2 2025 | -1485% | +1567 points |
| Q1 2025 | -1957% | N/A |
| Q4 2024 | -1637% | -1614 points |
| Q3 2024 | 29% | N/A |
ACIU has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ACIU on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
ACIU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$19.2M |
| Q1 2026 | $0 | +$23.1M |
| Q4 2025 | -$19.9M | -383% |
| Q3 2025 | -$22.1M | -$4.9M |
| Q2 2025 | -$19.2M | -122% |
| Q1 2025 | -$23.1M | -2575% |
| Q4 2024 | $7M | +$26.7M |
| Q3 2024 | -$17.2M | -$881.2K |
ACIU has burned cash in most quarters: −$42M over the past year, against −$53M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over ACIU on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACIU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.9% | -2M shares |
| 3 years | +17% | +14.5M shares |
| 5 years | +34% | +25M shares |
| Available history | +37% | +26.4M shares |
ACIU has 99M diluted shares, down 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $6,019 |
| Q4 2024 | — |
| Q3 2024 | — |
ACIU hasn't bought back shares in the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over ACIU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
ACIU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | -4.3x | Net Cash |
| Q3 2019 | -4.3x | Net Cash |
ACIU has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ACIU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 18.0 | Oversold |
ACIU's weekly RSI is 40 (neutral) and its Stochastic is 18 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ACIU PE vs Healthcare Sector
| Metric | ACIU | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ACIU has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
ACIU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.39 | 10% below |
| 20 week MA | $2.47 | 13% below |
| 50 week MA | $2.74 | 22% below |
| 100 week MA | $2.57 | 17% below |
| 200 week MA | $2.81 | 24% below |
ACIU is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ACIU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.39 | $5.51 | -34% |
| 2021 | $5.51 | $5.39 | -2.2% |
| 2022 | $5.39 | $1.75 | -68% |
| 2023 | $1.75 | $5.00 | +186% |
| 2024 | $5.00 | $2.73 | -45% |
| 2025 | $2.73 | $3.13 | +15% |
| 2026 YTD | $3.13 | $2.14 | -32% |
ACIU has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.